These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 7016966

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
    Gragnoli G, Tanganelli I, Signorini AM.
    Boll Soc Ital Biol Sper; 1980 Jan 15; 56(1):69-75. PubMed ID: 7002168
    [Abstract] [Full Text] [Related]

  • 3. Degradation and secretion of insulin in hepatic cirrhosis.
    Iwasaki Y, Ohkubo A, Kajinuma H, Akanuma Y, Kosaka K.
    J Clin Endocrinol Metab; 1978 Oct 15; 47(4):774-9. PubMed ID: 400732
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Studies of glucose intolerance in cirrhosis of the liver.
    Shankar TP, Solomon SS, Duckworth WC, Himmelstein S, Gray S, Jerkins T, Bobal MA, Iyer RS.
    J Lab Clin Med; 1983 Oct 15; 102(4):459-69. PubMed ID: 6352838
    [Abstract] [Full Text] [Related]

  • 6. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
    Sakai T, Ohneda A, Nihei J, Kobayashi T.
    Tohoku J Exp Med; 1982 Dec 15; 138(4):427-40. PubMed ID: 6761899
    [Abstract] [Full Text] [Related]

  • 7. [Pancreatic polypeptide response to oral glucose load in patients with liver cirrhosis--interrelationship between PP and other pancreatic endocrine hormones].
    Kawakami K.
    Nihon Naibunpi Gakkai Zasshi; 1988 Mar 20; 64(3):155-70. PubMed ID: 3294051
    [Abstract] [Full Text] [Related]

  • 8. Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal.
    Marchesini G, Melli A, Checchia GA, Mattioli L, Capelli M, Cassarani S, Zoli M, Pisi E.
    Metabolism; 1985 Aug 20; 34(8):695-701. PubMed ID: 3894876
    [Abstract] [Full Text] [Related]

  • 9. Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the liver.
    Shankar TP, Fredi JL, Himmelstein S, Solomon SS, Duckworth WC.
    Am J Med Sci; 1986 Apr 20; 291(4):248-54. PubMed ID: 3518447
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Behavior of C-peptide and immunoreactive insulin in essential obesity].
    Gragnoli G, Signorini AM, Tanganelli I, Martinelli G.
    Boll Soc Ital Biol Sper; 1979 Mar 30; 55(6):564-70. PubMed ID: 399187
    [Abstract] [Full Text] [Related]

  • 12. Insulin and C-peptide in ascitic fluid and plasma and their relative responses to glucagon in patients with cirrhosis.
    Akgün S, Samanta A, Ertel NH.
    J Endocrinol Invest; 1988 Dec 30; 11(11):789-93. PubMed ID: 3066813
    [Abstract] [Full Text] [Related]

  • 13. Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area.
    Fujita Y, Kozawa J, Iwahashi H, Yoneda S, Uno S, Yoshikawa A, Okita K, Eguchi H, Nagano H, Imagawa A, Shimomura I.
    Endocr J; 2015 Dec 30; 62(4):329-37. PubMed ID: 25740613
    [Abstract] [Full Text] [Related]

  • 14. Responses of plasma cyclic AMP, serum immunoreactive insulin, C-peptide immunoreactivity and blood sugar levels to glucagon in patients with liver diseases.
    Shimamura J, Taketa K, Ide T, Nakata K, Nagashima H.
    Acta Med Okayama; 1985 Oct 30; 39(5):385-96. PubMed ID: 3000142
    [Abstract] [Full Text] [Related]

  • 15. Plasma insulin, C-peptide, and blood glucose in portal, hepatic and peripheral veins in liver cirrhosis. Effect of intravenous tolbutamide.
    Pelkonen R, Kallio H, Suoranta H, Karonen SL.
    Acta Endocrinol (Copenh); 1981 Aug 30; 97(4):496-502. PubMed ID: 7023164
    [Abstract] [Full Text] [Related]

  • 16. Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes.
    Hiroyoshi M, Tateishi K, Yasunami Y, Maeshiro K, Ono J, Matsuoka Y, Ikeda S.
    Am J Gastroenterol; 1999 Apr 30; 94(4):976-81. PubMed ID: 10201468
    [Abstract] [Full Text] [Related]

  • 17. Pancreatic glucoregulatory hormones in cirrhosis of the liver: portal vein concentrations during intravenous glucose tolerance test and in response to a meal.
    Holst JJ, Burcharth F, Kühl C.
    Diabete Metab; 1980 Jun 30; 6(2):117-27. PubMed ID: 6997101
    [Abstract] [Full Text] [Related]

  • 18. [Plasma lipids, insulin, C-peptide, and glucagon levels in cirrhosis: personal observations].
    Luca M, Sfogliano L, Privitera P, Noto R.
    Riv Eur Sci Med Farmacol; 1989 Apr 30; 11(2):113-22. PubMed ID: 2678305
    [Abstract] [Full Text] [Related]

  • 19. Elevation of plasma glucagon-like immunoreactivity (GLI) in patients with liver cirrhosis.
    Watanabe A, Hashimoto M, Higashi T, Kobayashi M, Nakatsukasa H, Yamauchi Y, Watanabe M, Fujiwara M, Nagashima H.
    J Med; 1986 Apr 30; 17(2):95-108. PubMed ID: 3473162
    [Abstract] [Full Text] [Related]

  • 20. C-peptide in non-alcoholic cirrhosis and hepatocellular carcinoma.
    Pun KK, Ho PW, Yeung RT.
    J Endocrinol Invest; 1988 May 30; 11(5):337-43. PubMed ID: 2846676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.